Occipital neurostimulation in primary headaches: Update

A. Proietti Cecchini, M. Leone, V. Tullo, M. Curone, P. Di Fiore, G. Bussone

Research output: Contribution to journalArticlepeer-review


A subset of headache patients are chronic and results refractory to standard medical treatments, they are unsatisfied or unable to tolerate the side effects of medications. In the lack of more effective prophylactic treatment, there is need of alternative approach. Migraine is conceptualized as a chronic and potentially progressive disorder. It is conceivable that more aggressive therapeutic efforts could be warranted in drug-refractory chronic migraine. In this prospective, the new, device-based therapies that allow to affect brain function in less invasive ways may represent a therapeutic opportunity. Peripheral occipital neurostimulation resulted in several trials and case reports to be beneficial in a large variety of headache and craniofacial pain disorders, with chronic primary headache the most studied. We comment on our experience in the application of ONS in drug-refractory chronic cluster headache and chronic migraine patients.

Original languageEnglish
JournalNeurological Sciences
Issue numberSUPPL. 1
Publication statusPublished - 2013


  • Chronic migraine
  • Chronic pain
  • Cluster headache
  • Drug refractory
  • Neurostimulation
  • Occipital nerve

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Dermatology
  • Medicine(all)


Dive into the research topics of 'Occipital neurostimulation in primary headaches: Update'. Together they form a unique fingerprint.

Cite this